1. Home
  2. RCUS vs HIW Comparison

RCUS vs HIW Comparison

Compare RCUS & HIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$20.29

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

HIW

Highwoods Properties Inc.

HOLD

Current Price

$20.61

Market Cap

2.5B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
HIW
Founded
2015
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
RCUS
HIW
Price
$20.29
$20.61
Analyst Decision
Buy
Hold
Analyst Count
10
7
Target Price
$29.20
$27.71
AVG Volume (30 Days)
1.1M
1.3M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
9.50%
EPS Growth
N/A
54.26
EPS
N/A
1.45
Revenue
$247,000,000.00
$806,112,000.00
Revenue This Year
N/A
$6.67
Revenue Next Year
$70.88
$3.61
P/E Ratio
N/A
$14.51
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$20.50
52 Week High
$26.40
$32.76

Technical Indicators

Market Signals
Indicator
RCUS
HIW
Relative Strength Index (RSI) 43.14 32.16
Support Level $18.52 N/A
Resistance Level $21.55 $23.68
Average True Range (ATR) 1.08 0.56
MACD -0.27 0.02
Stochastic Oscillator 3.95 3.84

Price Performance

Historical Comparison
RCUS
HIW

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About HIW Highwoods Properties Inc.

Highwoods Properties Inc is a fully integrated office REIT that owns, develops, acquires, leases, and manages office properties mainly in the best business districts of Atlanta, Charlotte, Dallas, Nashville, Orlando, Raleigh, Richmond, and Tampa. Its principal business is the operation, acquisition, and development of rental office properties, with no material inter-segment transactions. The Company evaluates performance by geographic location, and the operating results by geographic grouping are regularly reviewed by the chief operating decision maker. The core portfolio consists mainly of office properties in its key markets, with the majority of revenue derived from its Raleigh properties.

Share on Social Networks: